Periodontal Diseases Clinical Trial
Official title:
Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics A Prospective, Double Blind, Randomized, Three Armed, Parallel, Placebo Controlled Clinical Trial
NCT number | NCT02185209 |
Other study ID # | PERI-IMPL |
Secondary ID | |
Status | Completed |
Phase | Phase 4 |
First received | |
Last updated | |
Start date | March 2015 |
Est. completion date | May 27, 2022 |
Verified date | August 2022 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to investigate if the use of systemic adjunctive antibiotics in the treatment of periimplantitis is needed.
Status | Completed |
Enrollment | 77 |
Est. completion date | May 27, 2022 |
Est. primary completion date | May 27, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Male or female =18-65 year 2. Patients who has been referred by a general dentist to a specialist clinic in periodontology for treatment of peri-implantitis. 3. Having sign of peri-implantitis around at least one osseointegrated dental implant that has been in function for = one year 4. Peri-implantitis is diagnosed when; PPD of = 6mm can be found at a dental implant in association with BOP and/or suppuration together with the loss of marginal alveolar bone of more than 2 mm detected on intraoral radiographs (giving radiographic exposure of at least = 3 fixture threads). 5. Partially or completely edentulous subjects with healthy or treated periodontal conditions enrolled in a regular supportive program. 6. Full-Mouth Plaque Score (FMPS) = 25 7. Signed informed consent Exclusion Criteria: 1. Known allergy to amoxicillin, penicillin (PcV), metronidazole or betalactamic 2. Contraindication for dental surgical treatment (i.e. immunocompromised, uncontrolled DM (B-GHb-A1C 8-9 %, 64-75 mmol/mol), osteoporosis, I.V bisphosphonate treatment due to malignancy, pregnant and lactating women). 3. Incapability to perform basal oral hygiene measures due to physical or mental disorders. 4. Received systemic antimicrobial therapy in the past three months. 5. Currently on allopurinol, digoxin, disulfiram, lithium, busulfan, 5-fluorouracil, methotrexate, phenytoin, cyclosporine and warfarin. 6. Known severe chronic peripheral or central disease of the nervous system 7. Known alcohol abuse 8. Known hepatic encephalopathy 9. Known lactose intolerance, galactose intolerance 10. Untreated periodontal condition. 11. Implant showing sign of mobility. 12. Implants with bone loss exceeding 2/3 of the length of the implant or implants with bone loss beyond any transverse openings in hollow implants. 13. Any medical condition or on any concomitant medication that, in the opinion of the investigator, might interfere with the evaluation of the study objectives or jeopardize patient safety Patients with xerostomia or having slow bowel motion will be excluded from the group of patients providing salivary and fecal samples. |
Country | Name | City | State |
---|---|---|---|
Sweden | Folktandvården Skanstull | Stockholm | |
Sweden | Folktandvården Kaniken | Uppsala |
Lead Sponsor | Collaborator |
---|---|
Margareta Hultin |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Probing pocket depth change and bone level stability | 0,6 and 12 months | ||
Secondary | Change of clinical soft tissue inflammation, bleeding on probing (BOP) | 0, post operative 12 month | ||
Secondary | Soft tissue recession (REC) and clinical attachment level gain (CAL) | 0,6 and 12 month | ||
Secondary | • Quantitative and qualitative change in levels of the peri-implant periopathogenic microflora | 0,6 and 12 months | ||
Secondary | • Susceptibility changes of the oral and intestinal microflora to amoxicillin, metronidazole and penicillin. | 0,6 and 12 month | ||
Secondary | Quantitative and qualitative changes in the oral and intestinal microflora | 0,6 and 12 month | ||
Secondary | Concentration of amoxicillin, metronidazole and PcV in saliva and feces | 0, 6 and 12 month | ||
Secondary | • Follow-up of adverse events related or unrelated to the investigated medical products | 0,6, and 12 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT04478864 -
Knowledge, Practice and State of Periodontal Health
|
||
Completed |
NCT03507868 -
YKL-40 and IL-6 Levels in Periodontal Disease
|
||
Completed |
NCT05720481 -
Impact of Periodontal Treatment on Growth Differentiation Factor-15 Levels
|
N/A | |
Recruiting |
NCT06052150 -
Oral Health In Cirrhosis of the Liver (ORACLE)
|
||
Recruiting |
NCT06025955 -
Evaluation of Outcomes of Minimally Invasive Non- Surgical Versus Surgical Therapy in Furcation Involvement.
|
N/A | |
Recruiting |
NCT03510702 -
SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
|
||
Completed |
NCT05631600 -
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05068778 -
Development of an AI App to Improve Compliance in Periodontal Maintenance Patients
|
||
Not yet recruiting |
NCT05178563 -
Mechanisms of Acute Inflammation Following Periodontal Treatment
|
N/A | |
Recruiting |
NCT06086821 -
Clinical Relevance of Different Time of Periodontal Re-evaluation
|
N/A | |
Recruiting |
NCT06224699 -
Toothpaste With Sodium Carbonate in Patients With Gingivitis
|
N/A | |
Not yet recruiting |
NCT05721313 -
Vital Root Amputation in Molars With Advanced Periodontal Furcation Involvement: a Preliminary Study
|
N/A | |
Completed |
NCT06306937 -
Serum Levels of Vitamin D and IL8 in Patients With Periodontitis
|
||
Completed |
NCT06040944 -
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
|
||
Recruiting |
NCT04669717 -
Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies
|
Phase 4 | |
Completed |
NCT05576142 -
Oral Findings in Pediatric Patients With Allergic Rhinitis and/or Asthma
|
||
Completed |
NCT04017078 -
Assessment of Carotid Artery Calcifications
|
||
Completed |
NCT03694496 -
The Effectiveness of an Oral Health Education Programme of Adolescents in Hong Kong
|
N/A |